The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Cancer Incidence in a Population-Based Cohort of Patients Hospitalized With Diabetes Mellitus in Denmark
Abstract
BACKGROUND: Diabetes has been associated with an increased risk of several cancers, notably cancers of the pancreas, liver, endometrium, and kidney. Since most previous studies have involved a limited sample size or focused on specific cancer sites, we conducted a comprehensive assessment of the risk of cancer in a nationwide cohort of diabetics in Denmark. METHODS: Discharge records of 109581 individuals hospitalized with a diagnosis of diabetes from 1977 through 1989 were linked with national cancer registry records through 1993. Standardized incidence ratios (SIRs) were calculated for specific cancer sites. RESULTS: The SIRs for primary liver cancer were 4.0 (95% confidence interval [CI] = 3.5-4.6) in males and 2.1 (95% CI = 1.6-2.7) in females. These SIRs remained elevated with increasing years of follow-up and after exclusion of patients with reported risk factors (e.g., cirrhosis and hepatitis) or patients whose cancers were diagnosed at autopsy. Kidney cancer risk was also elevated, with SIRs of 1.4 (95% CI = 1.2-1.6) in males and 1.7 (95% CI = 1.4-1.9) in females. For both sexes combined, the SIR for pancreatic cancer was 2.1 (95% CI = 1.9-2.4), with a follow-up time of 1-4 years; this SIR declined to 1.3 (95% CI = 1.1-1.6) after 5-9 years of follow-up. Excess risks were also observed for biliary tract and endometrial cancers. The SIRs for kidney and endometrial cancers declined somewhat after exclusion of diabetics with reported obesity. CONCLUSIONS: Patients hospitalized with a diagnosis of diabetes appear to be at higher risk of developing cancers of the liver, biliary tract, pancreas, endometrium, and kidney. The elevated risks of endometrial and kidney cancers, however, may be confounded by obesity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Physical activity also helps to prevent type 2 diabetes, which has been associated with increased risk of cancers of the colon, pancreas, and possibly other sites.[115][116][117][118]”
In the citing paper
“Physical activity also helps to prevent type 2 diabetes, which has been associated with increased risk of cancers of the colon, pancreas, and possibly other sites.[115][116][117][118]”
Citations
Cites
Harrison's Principles of Internal Medicine.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-499_2 · Cited by 12,528
Statistical Methods in Cancer Research
Breslow, N. E. (1980) · Cited by 7,332
Statistical Methods in Cancer Research. Volume II – The Design and Analysis of Cohort Studies
Juul, S. (1989) · Scandinavian Journal of Social Medicine · doi:10.1177/140349488901700214 · Cited by 3,602
Modern Nutrition in Health and Disease.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-508_7 · Cited by 3,381
Cancer Epidemiology and Prevention
Schottenfeld, D. (2006) · doi:10.1093/acprof:oso/9780195149616.001.0001 · Cited by 3,376
The American Journal of Gastroenterology
(2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.80003397.x · Cited by 2,202
Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors.
Wanless, I. R., & Lentz, J. S. (1990) · Hepatology · doi:10.1002/hep.1840120505 · Cited by 1,191
Principles and Practice of Gynecologic Oncology
Hoskins, W. J., Pérez, C. A., & Young, R. C. (1992) · Cited by 944
Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis
Everhart, J. (1995) · JAMA · doi:10.1001/jama.273.20.1605 · Cited by 747
(1980) · Environmental Pollution Series A Ecological and Biological · doi:10.1016/0143-1471(80)90144-0 · Cited by 633
Research works printed but not linked: 4
- Everhart, 1995, JAMA, 273, 1605, 10.1001/jama.1995.03520440059037 · DOI
- La Vecchia, 1990, Cancer Research, 50, 6274
- 1991, American Journal of Epidemiology, 132, 902
- 1988, 95, 1056
Cited by
Sorted by citations
Items 501–600 of 626
Singal, A. G., & Marrero, J. A. (2015) · Wiley eBooks · doi:10.1002/9781118512074.ch109 · Cited by 7
Lyngstrand, J. E., Bønnelykke‐Behrndtz, M. L., Laurberg, T., Røssell, E., & Sollie, M. (2024) · BMC Cancer · doi:10.1186/s12885-024-12598-8 · Cited by 6
“Five studies reported stratified risk measurements based on sex [22, 23, 25, 34, 41] and one study cohort only included men [33].”
BackgroundMethodInfluentialGlucagon-like Peptide-1 Receptor Agonists: Exciting Avenues Beyond Weight Loss
Sundararaman, L. V., Gouda, D., Kumar, A., Sundararaman, S., & Goudra, B. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14061978 · Cited by 7
“Other studies have reported an increased risk of pancreatic cancer associated with GLP1A usage [50,97], while some did not find such an association [98,99].”
Ali, S., Na, R., Tuesley, K., Spilsbury, K., Stewart, L. M., Coory, M. D., Webb, P. M., Donovan, P. J., Pearson, S., Jordan, S. J., et al. (2022) · Cancer Epidemiology · doi:10.1016/j.canep.2022.102266 · Cited by 6
Cui, X., Li, J., Yang, Y., Wu, J., Xu, H., Yu, Y., & Qin, G. (2022) · Journal of Diabetes · doi:10.1111/1753-0407.13329 · Cited by 6
Risk Factors for Ovarian Cancers: Do Subtypes Require Separate Treatment in Epidemiological Studies?
Sagae, S., Mori, M., & Moore, M. A. (2002) · PubMed · Cited by 6
Epidemiology and risk factors for exocrine pancreatic cancer
Sandberg, A. A., Hoem, D., & Dervenis, C. (2007) · Annals of Gastroenterology · Cited by 6
Epidemiology of Uterine Corpus Cancers
Brinton, L. A., Lacey, J. V., Devesa, S. S., & Sherman, M. E. (2004) · Elsevier eBooks · doi:10.1016/b978-0-443-07142-3.50018-x · Cited by 6
Kosti, A., Chen, H.-I. H., Mohan, S., Liang, S., Chen, Y., & Habib, S. L. (2015) · Genes & Cancer · doi:10.18632/genesandcancer.51 · Cited by 6
“Several epidemiological studies showed that diabetes is associated with an increased risk of cancer [1-8].”
BackgroundLam, K.-Y. (2002) · Endocrine Pathology · doi:10.1385/ep:13:1:39 · Cited by 6
Teixeira, P. P., Xu, Y. Y., Aravkin, A. Y., Zheng, P., Force, L. M., Kocarnik, J., McLaughlin, S. B., Vos, T., Lenox, H., Hay, S. I., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-13045-9 · Cited by 5
Thiamine: A Key Role In Human Health
Gochhayat, G., Kumar, M., Bhatt, S., Saini, V., & Malik, A. (2019) · International journal of scientific and technology research · Cited by 5
Select Endocrine Disorders and Exosomes in Early PDAC Diagnosis
Włodarczyk, B., Durko, Ł., Walczak, K., Talar‐Wojnarowska, R., & Malecka-Wojciesko, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212159 · Cited by 5
Role of breast cancer inhibitors on diabetes mellitus– an in silico approach
Rampogu, S. D. (2015) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/s40200-015-0138-1 · Cited by 5
“There are several reports delineating how diabetes mellitus triggers a variety of cancers [3-8].”
BackgroundAbbasi, M., Tarafdari, A. M., Esteghamati, A., Vejdani, K., & Nakhjavani, M. (2010) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2009.0112 · Cited by 5
Diabetes mellitus als prognostischer Marker beim Oropharynx- und Larynxkarzinom
Zaoui, K., Doll, J., Stiebi, P., Federspil, P. A., Plinkert, P. K., & Hess, J. (2016) · HNO · doi:10.1007/s00106-016-0177-z · Cited by 5
Draft toxicological profile for trichloroethylene
Todd, G., Ruíz, P., Mumtaz, M. M., Taylor, J., Wohlers, D., Diamond, G., Coley, C., & Citra, M. J. (2014) · Cited by 5
Søgaard, K. K., Veres, K., Vandenbroucke‐Grauls, C. M. J. E., Vandenbroucke, J. P., Sørensen, H. T., & Schønheyder, H. C. (2020) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-0705 · Cited by 5
“We also noted a high prevalence of diabetes in our cohort, known as a risk factor for both infection and cancer (28).”
BackgroundAssociation of Metformin With Volumetric Tumor Growth of Sporadic Vestibular Schwannomas
Armstrong, M. F., Lohse, C. M., Lees, K. A., & Carlson, M. L. (2021) · Otology & Neurotology · doi:10.1097/mao.0000000000003149 · Cited by 5
Clinical Epidemiology of Chronic Liver Disease: Hepatocellular Carcinoma
Suraweera, D., Konyn, P., Vu, T., & Saab, S. (2018) · Clinical Epidemiology of Chronic Liver Diseases · doi:10.1007/978-3-319-94355-8_15 · Cited by 6
Epidemiology and Risk Factors of Renal Cell Carcinoma
Meyer, A. R., Allaf, M. E., & Gorin, M. A. (2018) · Springer eBooks · doi:10.1007/978-3-319-92309-3_1 · Cited by 5
Power frequency electromagnetic fields, melatonin and the risk of breast cancer.
Swerdlow, A. J. (2006) · Cited by 5
Saha, B. K., Bhattacharya, R., & Chatterjee, M. (2002) · Cell Biochemistry and Function · doi:10.1002/cbf.946 · Cited by 5
Hepatocellular Carcinoma in NAFLD
Ratziu, V., & Poynard, T. (2004) · Wiley eBooks · doi:10.1002/9780470987438.ch22 · Cited by 5
Influence of diabetes mellitus and effectiveness of metformin on hepatocellular carcinoma
Ono, M., Fujita, K., Kobayashi, K., & Masaki, T. (2023) · Hepatology Research · doi:10.1111/hepr.13912 · Cited by 4
Insulin, Insulin Resistance, and Cancer Associations
Lipscombe, L. L. (2011) · Energy balance and cancer · doi:10.1007/978-1-4419-9911-5_5 · Cited by 4
“Several studies stratified findings by menopausal status [48, 56, 57] or limited their populations to predominantly postmenopausal women [46, 47, 52, 65, 67].”
BackgroundInfluentialHolmes, C. E., Ramos‐Niño, M. E., & Littenberg, B. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-289 · Cited by 4
“Background Epidemiologic studies have found an increase in cancer mortality and risk of several cancer types in persons with type 2 diabetes mellitus[1-4].”
BackgroundObesity, Diabetes, and Risk of Cancer
Larsson, S. C., Adami, H., & Wolk, A. (2006) · Humana Press eBooks · doi:10.1007/978-1-59259-985-1_14 · Cited by 4
Diabetes Mellitus and Risk of Colorectal Cancer
Larsson, S. C., Orsini, N., & Wolk, A. (2005) · Cited by 4
Li, X.-P. (2003) · World Journal of Gastroenterology · doi:10.3748/wjg.v9.i8.1848 · Cited by 4
Diabetes as a Risk Factor of Pancreatic Cancer
Mao, D. L. A. Y. (2015) · doi:10.3998/panc.2015.2 · Cited by 4
“(1, 3, 5, 6, 13, 14, 27, 39, 43, 47, 55, 58, 63, 73, 76, 77, 78, 84, 94, 95) with information on the association between diabetes and pancreatic cancer have been reported.”
Koteish, A. A., & Diehl, A. M. (2001) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-001-0020-8 · Cited by 3
Bancsik, K., Daina, L., Lorenzovici, L., Rossu, G., Bancsik, R., Ghitea, T. C., Ilea, C. D. N., & Daina, M. D. (2024) · Healthcare · doi:10.3390/healthcare12202031 · Cited by 3
“Men are often more involved in high-risk occupations and physical activities, which increases their likelihood of sustaining injuries requiring orthopedic and trauma care [27,30].”
BackgroundMetabolic Disease and Hepatocellular Carcinoma
Thiel, D. H. V., & Ramadori, G. P. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-376-3_9 · Cited by 3
Fujimoto, Y., Miyashita, H., & Sakuma, S. (2006) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.38.113 · Cited by 3
Incretin-based therapies and cancer risk: a review of recent literature safety data
Scavone, C., Sportiello, L., Rafaniello, C., Fiorentino, S., Cimmaruta, D., Rossi, F., & Capuano, A. (2016) · Diabetes Management · Cited by 3
Marciano, R., Servetto, A., Bianco, C., & Bianco, R. (2017) · Journal of Medical Case Reports · doi:10.1186/s13256-017-1443-8 · Cited by 3
Lee, Y. B., Lee, J. H., Choi, J. Y., Yu, D.-S., Han, K., & Park, Y. G. (2017) · Diabetes & Metabolism · doi:10.1016/j.diabet.2017.11.006 · Cited by 3
Epidemiology of Hepatocellular Carcinoma
White, D. L., & El‐Serag, H. B. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6082-5_4 · Cited by 4
Calvisi, D. F., Evert, M., & Dombrowski, F. (2009) · Archives of Physiology and Biochemistry · doi:10.1080/13813450902870457 · Cited by 2
“Although the epidemiological studies linking diabetes to the development of HCC were in the beginning unconvincing, the most recent investigations using a large cohort of patients indicate that diabetic people are at a significantly higher risk to develop liver cancer than normoglycaemic people (Adami et al., 1996; El…”
ResultBulum, T., Perić, Z., Bogeljić, M., Ostojić, A., Kovačević, V., Bukovski-Simonoski, S., Tambić-Andrašević, A., Anić, P., Duvnjak, L. S., Minigo, H., et al. (2009) · Diabetologia Croatica · Cited by 1
Are diabetics victims of oral cancer
Yadiyal, M., Shenoy, N., Shenoy, A. K., & Ahmed, J. (2013) · International Journal of Bioassays · doi:10.21746/ijbio.2013.06.0012 · Cited by 2
Pancreatic adenocarcinoma and aging: understanding the menace for better management
Zhou, T., Yan, J., Hao, J., & Yu, J. Q. (2023) · Journal of Pancreatology · doi:10.1097/jp9.0000000000000133 · Cited by 2
“…islet cells may occur in the elderly population, which seems to be the only specific finding of type 2 DM. [40] Many epidemiological studies have demonstrated that type 2 DM (T2DM) is a risk factor for PDAC, [41–47] which suggests that the elderly population with T2DM increases the risk of PDAC.”
BackgroundCurrent Perspectives of Immunotherapy for Hepatocellular Carcinoma
Liu, X., Lei, X., Huang, S., & Yang, X. (2023) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/0113862073255266231025111125 · Cited by 2
Chen, Y., Huang, S., Cheng, Y., Hsu, Y., & Lan, C.-C. E. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123083 · Cited by 2
Introductory Chapter: Etiology and Pathogenesis of Hepatocellular Carcinoma
Streba, C. T., Vere, C. C., Rogoveanu, I., & Florescu, N. D. (2018) · IntechOpen eBooks · doi:10.5772/intechopen.78328 · Cited by 2
Hepatocellular Carcinoma: Epidemiology and Etiology
Degli, D., Soffritti, M., Lemoine, A., Tibaldi, E., & Manservigi, M. (2012) · InTech eBooks · doi:10.5772/30709 · Cited by 2
“Diabetes has been also shown to be an independent risk factor for HCC, with an increase in the risk ranging from 1.8 to 4 times in Swedish, Danish and Greek cohorts (Adami et al., 1996; Wideroff et al., 1997; Lagiou et al., 2000).”
InfluentialCancer Predisposition in Diabetic Patients: Risk Assessment and Targeted Preventive Measures
Cebioglu, M., Schild, H. H., & Golubnitschaja, O. (2013) · Advances in predictive, preventive and personalised medicine · doi:10.1007/978-94-007-5971-8_13 · Cited by 2
HCC Screening and Surveillance
Masuzaki, R., & Omata, M. (2009) · CRC Press eBooks · doi:10.3109/9780203092880-4 · Cited by 2
Hepato‐biliary and Pancreatic Function
Masclee, A., & van Hoek, B. (2004) · Wiley eBooks · doi:10.1002/0470013877.ch7 · Cited by 2
“Several studies have provided evidence that the risk of pancreatic cancer is increased in patients with type 1 and type 2 diabetes mellitus [136,137].”
BackgroundThe Effect of Endocrine Diseases on Liver Function
DeSantis, A. J., & Blei, A. T. (2007) · doi:10.1002/9780470691861.ch20i · Cited by 2
Liver transplantation for alcohol-associated liver disease: The changing landscape
Yildiz, E., Zaffar, D., Öztürk, N. B., Gürakar, M., Donmez, A. E., Toruner, M. D., Şimşek, C., & Gurakar, A. O. (2025) · Hepatology forum/Hepatology forum (Online) · doi:10.14744/hf.2024.2024.0057 · Cited by 1
“[45 ] Coinfection with viral hepatitis B and C is also a significant enhancer of ALD.”
Obesity, Inflammation, Nonalcoholic Fatty Liver Disease, and Hepatocellular Carcinoma
Alkhouri, N., & McCullough, A. J. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6819-6_9 · Cited by 1
A Study on Plant Based Dietary Patterns and Cancer Risk
Purada, N., Matada, K., Philippe, M. M., & Koneri, R. (2013) · Cited by 1
Mohammadzade, F., Maryam, F., Alireza, S., & Mohammadali, V. (2016) · West Indian Medical Journal · doi:10.7727/wimj.2015.257 · Cited by 1
“Furthermore, the association of diabetes mellitus with gastric and esophageal cancer have been identified (14,15).”
BackgroundCoexistence of Type-1 Diabetes Mellitus and Papillary Thyroid Carcinoma
Çalapkulu, M., Sencar, M. E., Düğer, H., Bayram, S. M., Ünsal, İ. Ö., Çakal, E., & Özbek, M. (2019) · Current Diabetes Reviews · doi:10.2174/1573399815666191104114551 · Cited by 1
Metabolic Disease and Hepatocellular Carcinoma
Thiel, D. H. V., Alwahsh, S. M., & Ramadori, G. P. (2016) · Springer eBooks · doi:10.1007/978-3-319-34214-6_19 · Cited by 1
(2023) · Journal of Gastroenterology & Digestive Systems · doi:10.33140/jgds.07.01.04 · Cited by 1
“7) compared with the general population in a large-scale Danish study [21].”
Falco, V. D., Vitale, P., Brancati, C., Cicero, G., Auriemma, A., & Addeo, R. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1252407 · Cited by 1
Diabetes Mellitus and the Risk of Carcinogenesis: An Interdisciplinary Approach
Tkaczenko, H., Kamiński, P., & Kurhaluk, N. (2024) · Interdisciplinary cancer research · doi:10.1007/16833_2024_426 · Cited by 1
Bucharskaya, A. B., Terentyuk, G. S., Maslyakova, G. N., Matveeva, O. V., Наволокин, Н. А., Дихт, Н. И., Khlebzov, N. G., & Khlebzov, B. N. (2012) · Izvestiya of Saratov University Physics · doi:10.18500/1817-3020-2012-12-2-31-37 · Cited by 1
The diabetes mellitus and oncopathоlogy
Zhuravlyova, L., & Сокольникова, Н. В. (2021) · Medicine of Ukraine · doi:10.37987/1997-9894.2021.2(248).229022 · Cited by 1
Stocks, T. (2009) · DiVA at Umeå University (Umeå University) · Cited by 1
Ultraviolet light, autoimmune disorders and the etiology of malignant lymphomas
Smedby, K. E. E. (2005) · Figshare · Cited by 1
Diet and gastrointestinal cancer : one-carbon metabolism and other aspects
Larsson, S. C. (2006) · Figshare · doi:10.13140/rg.2.2.36541.67040 · Cited by 1
Multimorbidität in der EPIC-Potsdam Studie
Schienkiewitz, A. (2007) · DepositOnce · doi:10.14279/depositonce-1629 · Cited by 1
“Für Tumoren in Oesophagus, Kolorektum, Brust (postmenopausale Frauen), Endometrium und Niere wurde Übergewicht ebenfalls als Risikofaktor identifiziert (149, 198).”
BackgroundInfluentialMyers, I. (2014) · Cited by 1
Kaaks, R. (2003) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-08602-5_9 · Cited by 1
Dhaniram, D., Collins, A., Singh, K., & Voulvoulis, N. (2011) · doi:10.1002/9781119950127.ch6 · Cited by 1
Diet and Endometrial Cancer : Insulin related factors
Friberg, E. (2009) · Figshare
Managing Common Conditions Associated with Diabetes
Dunning, T. (2009) · doi:10.1002/9781444320893.ch10
New Challenges of the NAFLD and HIV Epidemics
Anstee, Q. M., & Main, J. (2011) · doi:10.1002/9781119962205.ch6
Diabetes, physical activity and endometrial cancer
Friberg, E. (2006) · Figshare
ENVIRONMENTAL CORRELATES OF PHYSICAL ACTIVITY IN YOUNG ADULTS
Jekal, Y. (2005) · D-Scholarship@Pitt (University of Pittsburgh)
Gordon-Dseagu, V. (2014) · UCL Discovery (University College London)
Diabetes and Pancreatic Cancer: Reply
Bonelli, L. A., Micheli, A. D., & Pugliese, V. (2004) · Pancreas · doi:10.1097/00006676-200405000-00019
Vindas, M. V. (2008) · Gredos (University of Salamanca) · doi:10.14201/gredos.17908
Kamath, S. J., Kamath, G. M., & Roopashree (2014) · Online Journal of Health and Allied Sciences
Obesity Management: Considerations for the Gastroenterologist
Gramlich, L. M., Zeman, M., & Sharma, A. M. (2010) · Wiley eBooks · doi:10.1002/9781444314403.ch25
Endogenous hormones in the etiology of ovarian and endometrial cancers
Lukanova, A. (2004) · DiVA at Umeå University (Umeå University)
Glynn, T. J., Hong, Y., Smith, R. A., Taubert, K. A., Thun, M. J., Clark, N. G., Doyle, C., Gansler, T. S., Eyre, H. J., & Kahn, R. (2005)
Gedruckt mit Genehmigung des Fachbereichs Veterinärmedizin der Freien Universität Berlin
Brunnberg, L., Staufenbiel, R., Zessin, K.-H., & Fries, R. (2009)
Signal Transduction Pathways Involved in Hepatocarcinogenesis and Metastasis of Hepatoma
Aravalli, R. N. (2010) · Cancer metastasis · doi:10.1007/978-90-481-9522-0_14
de Moraes, V. M. (2002) · Americanae (AECID Library)
Castillo, J. J., Mull, N. K., Reagan, J. L., Nemr, S., & Mitri, J. (2012)
Nutritional Management in the Patient with an Upper Gastrointestinal Cancer
Scolapio, J. S., & Ferrone, M. (2005) · CRC Press eBooks · doi:10.1201/9781420038309.ch12
O EFEITO DA DIABETES MELLITUS NOS PROCESSOS DE REENDOTELIZAÇÃO E ANGIOGÉNESE
Lima, M. G. A. (2014) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/5wsf-3390
Impact of Diabetes on Colorectal Cancer Outcomes
Shah, N. A. (2012) · doi:10.33915/etd.669
Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma
(2017) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9781681084657117010011
Washio, M., & Mori, M. (2017) · Journal of Clinical & Experimental Nephrology · doi:10.21767/2472-5056.100034
“The incidence of kidney cancer is high in Western Europe, Northern Europe, and North America while it is low in Asia [1,2].”
BackgroundTakahashi, P. (2015) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2015.tde-01072015-092915
Epigenetic Regulations in the Pathogenesis of HCC and the Clinical Application
Puszyk, W. M., Robertson, K. D., & Liu, C. (2017) · Molecular pathology library · doi:10.1007/978-3-319-68082-8_5
Development of Korean Gastric Cancer Risk Model using Logistic Regression and Neural Network
송민교 (2015) · Seoul National University Open Repository (Seoul National University)
Martín‐Renedo, J. (2011) · Buleria (Universidad de León) · doi:10.18002/10612/1751
Dellal, F. D., Polat, Ş. B., Yazıcıoğlu, M. Ö., Doğan, H. T., Ersoy, R., & Çakır, B. (2019) · Ankara Medical Journal · doi:10.17098/amj.581998
Metadata
- Authors
- Wideroff, L., Gridley, G., Chow, W. H., Linet, M., Mellemkjaer, L., Olsen, J. H., Keehn, S., & Borch-Johnsen, K.
- Affiliations
- National Institutes of Health (US)
- National Cancer Institute (US)
- Danish Cancer Society (DK)
- Information Management Services (US)
- University of Copenhagen (DK)
- Corresponding author
- Wideroff, L.
- ORCID
- Olsen, J. H.
- Venue
- JNCI Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 1997-09-17
- Volume
- 89
- Issue
- 18
- Pages
- 1360-1365
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2122576167
- Cited by
- 627
- References
- 42
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 9 · 2023: 13 · 2022: 14 · 2021: 16 · 2020: 8 · 2019: 19 · 2018: 12 · 2017: 20 · 2016: 20 · 2015: 28 · 2014: 38 · 2013: 43 · 2012: 42
- FWCI
- 2.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JNCI Journal of the National Cancer Institute (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Keywords
- diabetes mellitus, cancer incidence, liver cancer, pancreatic cancer, kidney cancer, endometrial cancer, biliary tract cancer, obesity, standardized incidence ratio, diabetes and cancer association
- MeSH terms
- Denmark, Female, Hospitalization, Humans, Male, Medical Record Linkage, Middle Aged, Neoplasms, Registries, Risk, Cohort Studies, Incidence, Age Distribution, Sex Distribution, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review